Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...
Jade Biosciences is a pre-revenue biotech focused on JADE101 for IgA nephropathy, offering potential. Read why I rate JBIO ...
Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.
SAN FRANCISCO, April 17, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Gossamer Bio, Inc. (NASDAQ: GOSS) and an executive, seeking to represent investors who purchased ...
PM UTC It will lose patent exclusivity within the next two years, but Merck has earned approval for a new, subcutaneous ...
Cautionary Language Concerning Forward-Looking Statements ...
Following surgery for chronic subdural hematoma, patients face a twofold increased risk for mortality and cognitive deficits ...
As of April 8, 2026, sentiment around Gossamer Bio, Inc. (NASDAQ:GOSS) remains cautious, with 56% of covering analysts ...
Wearable device data may help detect and track idiopathic pulmonary arterial hypertension, a rare lung disease, a study ...
The American College of Cardiology (ACC) and the Korean Society of Cardiology (KSC) will host the ACC Asia 2026 Together with KSC Spring Conference on April 17-18 in Gyeongju, South Korea. The ...
Glasgow Times on MSN
New cancer treatments approved for NHS Scotland in major medicine update
Scottish Medicines Consortium approves new NHS Scotland drugs for lung cancer, leukaemia, cervical cancer, pulmonary ...
Blood pressure afflicts nearly half of U.S. adults and some kinds of it resist current treatment, but research is pointing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results